A case of ceftriaxone-induced immune haemolytic anaemia in an ambulatory care setting
Background: Drug-induced immune haemolytic anaemia (DIIHA) is a rare adverse effect which varies between mild to fatal (Garratty, 2010). One of the most common class of drugs reported to cause severe DIIHA are the second and third generation cephalosporins (e.g. ceftriaxone) (Garratty, 2010; Hill et...
Main Authors: | Rakhee Mistry, Luke S.P. Moore, Nabeela Mughal, Andrew Godfrey, Stephen Hughes |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-01-01
|
Series: | Clinical Infection in Practice |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2590170224000013 |
Similar Items
-
Haematological Profile in Haemolytic Anaemia
by: R.H. Deshpande, et al.
Published: (2012-04-01) -
Hard-To-Treat Idiopathic Refractory Autoimmune Haemolytic Anaemia with Reticulocytopenia
by: Marcelo Aveiro, et al.
Published: (2020-12-01) -
Copper-induced Haemolytic Anaemia
by: Joana Azevedo Carvalho, et al.
Published: (2021-10-01) -
Autoimmune Haemolytic Anaemia and Multiple Autoimmune Syndrome
by: Mohammad Mahdi Adib Sereshki, et al.
Published: (2019-04-01) -
Distinct lipid profile in haemolytic anaemia-related gallstones compared with the general gallstone
by: Ziqi Wan, et al.
Published: (2023-12-01)